Johnson & Johnson
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Johnson & Johnson (JNJ) Business News
Track Johnson & Johnson in real time with a live news feed covering Johnson & Johnson stock news, official press releases, company announcements, and an archive of historical Johnson & Johnson news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Johnson and Johnson Raises Dividend for 64th Consecutive Year
Johnson & Johnson CFO on the company's robotic surgical system
Johnson & Johnson (JNJ) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Tuesday's Morning Movers: ORCL & BE Extend Partnership, KMX & JNJ Earnings
Johnson & Johnson beats quarterly revenue estimates, maintains full-year outlook
Dow Jones' J&J Slips Despite Beating First-Quarter Calls, Hiking Guidance
Stocks Eye More Gains Amid Peace Deal Hopes
Johnson & Johnson (JNJ) Surpasses Q1 Earnings and Revenue Estimates
Is Johnson & Johnson (JNJ) 27.0% Overvalued After Q1 2026? Revenue $24.06B (beat vs $23.63B est.), GAAP EPS $2.14 (miss vs $2.20 est.), Adjusted EPS $2.70 (beat); GF Score 88/100
Breakfast News: Novo Seeks Edge With OpenAI Deal
Johnson and Johnson Raises Dividend for 64th Consecutive Year
12:55 PM | Tuesday | Apr 14, 2026
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) declared its 64th consecutive annual dividend increase on April 14, 2026, lifting its quarterly payout from $1.30 per share to $1.34 per share, a 3% increase.
Read full article
Johnson and Johnson Raises Dividend for 64th Consecutive Year
24/7 Wall StreetJohnson & Johnson (NYSE:JNJ | JNJ Price Prediction) declared its 64th consecutive annual dividend increase on April 14, 2026, lifting its quarterly payout from $1.30 per share to $1.34 per share, a 3% increase.
Read full article
Johnson & Johnson CFO on the company's robotic surgical system
CNBC TelevisionJohnson & Johnson CFO Joseph Wolk discusses the company's latest FDA application for its OTTAVA robotic surgical system.
Read full article
Johnson & Johnson (JNJ) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks Investment ResearchAlthough the revenue and EPS for Johnson & Johnson (JNJ) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read full article
Tuesday's Morning Movers: ORCL & BE Extend Partnership, KMX & JNJ Earnings
Schwab NetworkOracle's (ORCL) rebound rally continues after extending a partnership with Bloom energy (BE). Diane King Hall explains why the headline offers a bullish catalyst for both companies.
Read full article
Johnson & Johnson beats quarterly revenue estimates, maintains full-year outlook
Proactive InvestorsJohnson & Johnson (NYSE:JNJ) reported first-quarter results on Tuesday that beat Wall Street expectations for revenue, driven by solid growth across its pharmaceutical and medical technology businesses. The healthcare conglomerate posted revenue of $24.06 billion for the quarter, up 9.9% from a year earlier and above analysts' estimates of $23.61 billion.
Dow Jones' J&J Slips Despite Beating First-Quarter Calls, Hiking Guidance
Investors Business DailyJohnson & Johnson stock fell early Tuesday despite better-than-expected first-quarter sales and earnings, and a guidance boost.
Read full article
Stocks Eye More Gains Amid Peace Deal Hopes
Schaeffers ResearchDow futures are flat this morning, but the S&P 500 and Nasdaq-100 are headed for gains amid peace deal hopes
Read full article
Johnson & Johnson (JNJ) Surpasses Q1 Earnings and Revenue Estimates
Zacks Investment ResearchJohnson & Johnson (JNJ) came out with quarterly earnings of $2.7 per share, beating the Zacks Consensus Estimate of $2.67 per share. This compares to earnings of $2.77 per share a year ago.
Is Johnson & Johnson (JNJ) 27.0% Overvalued After Q1 2026? Revenue $24.06B (beat vs $23.63B est.), GAAP EPS $2.14 (miss vs $2.20 est.), Adjusted EPS $2.70 (beat); GF Score 88/100
GuruFocusOn April 14, 2026, Johnson and Johnson (JNJ) released its 8-K filing detailing first-quarter 2026 results. Reported sales rose 9.9% year over year to $24.06 billi
Read full article
Breakfast News: Novo Seeks Edge With OpenAI Deal
Fool - Investing NewsNVO pushes for AI transformation, Bloom Energy and Oracle deepen partnership, and more
Read full article